Company Filing History:
Years Active: 1989-1991
Title: Marc Meier: Innovator in Imidazodiazepine Derivatives
Introduction
Marc Meier is a notable inventor based in Village-Neuf, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of imidazodiazepine derivatives. With a total of 2 patents, his work focuses on addressing various disorders of the central nervous system.
Latest Patents
Marc Meier's latest patents include innovative compounds designed for the control and prevention of convulsions, anxiety states, stress conditions, excitation states, and sleep disorders. One of his notable patents describes imidazodiazepine derivatives characterized by specific chemical formulas that allow for selective antagonism of activities exhibited by 1,4-benzodiazepines. These compounds are aimed at providing therapeutic benefits for individuals suffering from various mental health issues.
Career Highlights
Throughout his career, Marc Meier has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and has the potential to improve the quality of life for many patients.
Collaborations
Marc has collaborated with esteemed colleagues such as Walter Hunkeler and Emilio Kyburz. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Marc Meier's contributions to the field of pharmaceuticals, particularly through his patents on imidazodiazepine derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of central nervous system disorders.